GFP-Grb2 Translocation Assay Using High-content Imaging to Screen for Modulators of EGFR-signaling

Julia Petschnigg1, Robin Ketteler1

  • 1MRC Laboratory for Molecular Cell Biology, University College London, London, United Kingdom.

Bio-Protocol
|September 23, 2017
PubMed

Insights

High-content screening uses image-based readouts to study cellular pathways. This method, utilizing Growth Factor Receptor-bound protein 2 (GRB2) translocation, aids in identifying genes and compounds affecting EGFR signaling.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • High-content screening (HCS) is a powerful technique for analyzing complex cellular processes.
  • Image-based readouts, such as protein localization changes, are key to HCS assays.
  • Growth Factor Receptor-bound protein 2 (GRB2) exhibits translocation, making it a useful reporter.

Purpose of the Study:

  • To leverage HCS with GRB2 translocation to understand EGFR signaling.
  • To identify genes involved in EGFR signaling pathways.
  • To apply HCS for early-stage drug discovery targeting EGFR signaling.

Main Methods:

  • Utilizing a GFP-tagged GRB2 reporter protein.
  • Monitoring GRB2 translocation via image-based readouts in response to growth factor receptor stimulation.
  • Adapting the assay for cDNA expression cloning and compound screening.

Main Results:

  • Previous studies successfully identified genes involved in EGFR signaling using GFP-tagged GRB2 (Petschnigg et al., 2017).
  • The HCS assay is adaptable for cDNA expression cloning (Freeman et al., 2012).
  • The assay can identify compounds modulating or inhibiting EGFR signaling and internalization (Antczak and Djaballah, 2016).

Conclusions:

  • High-content screening with GRB2 translocation is effective for dissecting EGFR signaling.
  • This approach facilitates the discovery of genes and small molecules impacting cellular pathways.
  • The method holds significant potential for early-stage drug discovery and target identification.